TNF and psoriasis: Interestingly, PsoProtect data2 showed a higher frequency of hospitalisation amongst psoriasis patients on IL‐23 inhibitors compared with anti‐TNF and IL‐17 inhibitors; however, this was not found to be statistically significant, thus warranting larger studies to establish any possible association.